Patents by Inventor Jose-Carlos Gutierrez-Ramos

Jose-Carlos Gutierrez-Ramos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Th2-specific molecules and uses thereof
    Publication number: 20050202013
    Abstract: Novel Th2-specific polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length Th2-specific proteins, the invention further provides isolated Th2-specific fusion proteins, antigenic peptides, and anti-Th2-specific antibodies. The invention also provides Th2-specific nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a Th2-specific gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: May 3, 2005
    Publication date: September 15, 2005
    Inventors: Anthony Coyle, Stephen Manning, Sophie Lehar, Jose-Carlos Gutierrez-Ramos
  • Antibodies to polypeptide molecules of the G protein-coupled heptahelical receptor superfamily and uses therefor
    Publication number: 20030162943
    Abstract: Novel D6 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length D6 proteins, the invention further provides isolated D6 fusion proteins, antigenic peptides and anti-D6 antibodies. The invention also provides D6 nucleic acid molecules, recombinant expression vectors containing nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a D6 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: June 7, 2002
    Publication date: August 28, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Gerard J. Graham, Robert J. Benjamin Nibbs, Jose-Angel Gonzalo, Jose-Carlos Gutierrez-Ramos
  • Novel Th2-specific molecules and uses thereof
    Publication number: 20020164697
    Abstract: Novel Th2-specific polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length Th2-specific proteins, the invention further provides isolated Th2-specific fusion proteins, antigenic peptides, and anti-Th2-specific antibodies. The invention also provides Th2-specific nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a Th2-specific gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: November 20, 2001
    Publication date: November 7, 2002
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Anthony J. Coyle, Stephen Manning, Sophie Lehar, Jose-Carlos Gutierrez-Ramos
  • Polypeptide molecules of the G protein-coupled heptahelical receptor superfamily and uses therefor
    Patent number: 6403767
    Abstract: The present invention provides novel D6 polypeptides and proteins, as well as isolated D6 fusion proteins, antigenic peptides and anti-D6 antibodies. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: June 11, 2002
    Assignees: Millenium Pharmaceuticals, Inc., CRC Technology Limited
    Inventors: Gerard J. Graham, Robert J. Benjamin Nibbs, Jose-Angel Gonzalo, Jose-Carlos Gutierrez-Ramos
  • Nucleic acid molecules of the protein-coupled heptahelical receptor superfamily and uses therefor
    Patent number: 6287805
    Abstract: Novel D6 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length D6 proteins, the invention further provides isolated D6 fusion proteins, antigenic peptides and anti-D6 antibodies. The invention also provides D6 nucleic acid molecules, recombinant expression vectors containing nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a D6 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: March 20, 1998
    Date of Patent: September 11, 2001
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Gerard J. Graham, Robert J. Benjamin Nibbs, Jose-Angel Gonzalo, Jose-Carlos Gutierrez-Ramos
  • Nucleic acid molecules encoding monocyte chemotactic protein 5 (MCP-5) molecules and uses therefor
    Patent number: 6274342
    Abstract: The present invention relates to the discovery of novel genes encoding Monocyte Chemotactic Protein-5 (MCP-5) polypeptides. Therapeutics, diagnostics and screening assays based on these molecules are also disclosed.
    Type: Grant
    Filed: November 8, 1996
    Date of Patent: August 14, 2001
    Assignee: Center for Blood Research, Inc.
    Inventors: Jose-Carlos Gutierrez-Ramos, Gui-Quan Jia, Jose-Angel Gonzalo